Labcorp reported a 6.9% revenue increase to $3.81 billion and a 14.5% rise in adjusted EPS to $4.78 for Q3 2026, driven by organic growth and acquisitions. The company raised its full-year revenue growth guidance to 5.9%-6.7% and adjusted EPS to $18.30-$18.70, reflecting strong operational performance and margin expansion. Labcorp advanced its M&A strategy with four accretive transactions and received FDA approval for a melanoma diagnostic test, enhancing its specialty testing leadership. These developments position Labcorp for sustainable long-term growth in personalized medicine and diagnostics.
Labcorp's strong Q3 2026 results and raised full-year guidance provide context for readers. For those following the Health sector, here is Pluang's market snapshot as of Oct 28, 2026 16:41 WIB: Among 150 priced Health-sector US stocks tradable on Pluang, 47 rose and 92 fell today. Notable movers include BNGO at USD 1.12 with a 1-day change of -8.20%, ACB at USD 4.44 up 6.99%, and INO at USD 0.93 up 4.72% with Pluang order activity showing 54% Sell and 46% Buy and a typical hold time of 43 days.
Arcutis Biotherapeutics has appointed Dr. Rob Scott, a seasoned pharmaceutical executive with over 40 years of experience, to its Board of Directors. Dr. Scott's expertise in developing and securing approvals for innovative medicines, including derma...
Air Canada and CAE announced the opening of applications on November 1, 2026, for the 2027 Commandante-Judy-Cameron scholarships. These scholarships support up to eight Canadian women pursuing professional pilot or aircraft maintenance technician tra...
The Legacy Lab by Team One released its 2026 Legacy Makers 100 list, identifying brands consumers trust to have their best interests at heart and remain relevant long-term. St. Jude Children's Research Hospital topped the list for the second year. Th...
Circuit Mind has introduced AVE (Agentic Verification Engine), an AI-powered application that verifies printed circuit board (PCB) schematics against datasheets and internal design rules to catch errors early and avoid expensive respins. AVE compleme...
Grabar Law Office is investigating claims against officers and directors of Erasca, Planet Fitness, PROCEPT BioRobotics, and The Simply Good Foods Company for alleged breaches of fiduciary duties. The investigations focus on misleading statements and...
